Chinese Vaccine

Recent Highlights

Chinese COVID-19 vaccine CoronaVac shows 78 percent efficacy in Phase 3 trials in Brazil

Chinese COVID-19 vaccine CoronaVac shows 78 percent efficacy in Phase 3 trials in Brazil

Chinese officials have said that COVID-19 vaccine will be ready for the public by November

CanSino Biologics to begin final phase of human trials for its COVID-19 vaccine in Saudi Arabia

Chinese vaccine against COVID-19 safe, induces immune response, finds phase two clinical trial

All Stories for Chinese Vaccine

China allows limited use of COVID-19 vaccine CanSino for their military after clinical trials shows its effectiveness
• 5 years ago
The vaccine has been approved for a period of one year after clinical trials proved it was safe and showed some efficacy.
Chinese military gets approval to run clinical tests of experimental Coronavirus vaccine on human being
• 5 years ago
AMS’ candidate, named ARCoV, uses mRNA technology, an approach also used by Moderna Inc in the United States and German firm CureVac.

Home Video Shorts Live TV